K Visser

Summary

Affiliation: Leiden University Medical Center
Country: The Netherlands

Publications

  1. ncbi Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature
    K Visser
    Department of Rheumatology, Leiden University Medical Center, C1 R, P O Box 9600, 2300 RC Leiden, The Netherlands
    Clin Exp Rheumatol 27:1017-25. 2009
  2. doi A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study
    K Visser
    Department of Rheumatology C1 R, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
    Ann Rheum Dis 69:1333-7. 2010
  3. pmc Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature
    K Visser
    Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
    Ann Rheum Dis 68:1094-9. 2009
  4. pmc Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E
    K Visser
    Leiden University Medical Center, Department of Rheumatology, Leiden, The Netherlands
    Ann Rheum Dis 68:1086-93. 2009
  5. doi Towards personalized treatment: predictors of short-term HAQ response in recent-onset active rheumatoid arthritis are different from predictors of rapid radiological progression
    L Dirven
    Leiden University Medical Centre, Leiden, The Netherlands
    Scand J Rheumatol 41:15-9. 2012
  6. ncbi Use of methotrexate in undifferentiated arthritis
    K Visser
    Leiden University Medical Center, Leiden, The Netherlands
    Clin Exp Rheumatol 28:S117-21. 2010
  7. ncbi A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study
    L Heimans
    Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
    Ann Rheum Dis 73:1356-61. 2014
  8. doi The relationship between disease activity and depressive symptoms severity and optimism--results from the IMPROVED study
    L Heimans
    Department of Rheumatology, Leiden University Medical Center, PO Box 9600, 2300 RC, Leiden, The Netherlands
    Clin Rheumatol 32:1751-7. 2013

Collaborators

Detail Information

Publications8

  1. ncbi Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature
    K Visser
    Department of Rheumatology, Leiden University Medical Center, C1 R, P O Box 9600, 2300 RC Leiden, The Netherlands
    Clin Exp Rheumatol 27:1017-25. 2009
    ....
  2. doi A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study
    K Visser
    Department of Rheumatology C1 R, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
    Ann Rheum Dis 69:1333-7. 2010
    ..To develop a matrix model for the prediction of rapid radiographic progression (RRP) in subpopulations of patients with recent-onset rheumatoid arthritis (RA) receiving different dynamic treatment strategies...
  3. pmc Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature
    K Visser
    Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
    Ann Rheum Dis 68:1094-9. 2009
    ..To review systematically the available literature on the optimal dosage and route of administration of methotrexate in patients with rheumatoid arthritis (RA), as an evidence base for generating clinical practice recommendations...
  4. pmc Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E
    K Visser
    Leiden University Medical Center, Department of Rheumatology, Leiden, The Netherlands
    Ann Rheum Dis 68:1086-93. 2009
    ..To develop evidence-based recommendations for the use of methotrexate in daily clinical practice in rheumatic disorders...
  5. doi Towards personalized treatment: predictors of short-term HAQ response in recent-onset active rheumatoid arthritis are different from predictors of rapid radiological progression
    L Dirven
    Leiden University Medical Centre, Leiden, The Netherlands
    Scand J Rheumatol 41:15-9. 2012
    ..However, for some patients this outcome is less relevant, whereas short-term functional ability is relevant to all. Do these various treatment goals share the same predictors?..
  6. ncbi Use of methotrexate in undifferentiated arthritis
    K Visser
    Leiden University Medical Center, Leiden, The Netherlands
    Clin Exp Rheumatol 28:S117-21. 2010
    ..During the last few years, more data on interventions in UA have become available that provide guidance in the prescription of drugs to UA patients...
  7. ncbi A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study
    L Heimans
    Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
    Ann Rheum Dis 73:1356-61. 2014
    ..To assess which treatment strategy is most effective in inducing remission in early (rheumatoid) arthritis...
  8. doi The relationship between disease activity and depressive symptoms severity and optimism--results from the IMPROVED study
    L Heimans
    Department of Rheumatology, Leiden University Medical Center, PO Box 9600, 2300 RC, Leiden, The Netherlands
    Clin Rheumatol 32:1751-7. 2013
    ..Depression scores are associated with pain and unwell being but not with swollen joint counts and inflammatory parameters...